Cargando…

Impact of contrast agent injection duration on dynamic contrast‐enhanced MRI quantification in prostate cancer

The volume transfer constant K (trans), which describes the leakage of contrast agent (CA) from vasculature into tissue, is the most commonly reported quantitative parameter for dynamic contrast‐enhanced (DCE‐) MRI. However, the variation in reported K (trans) values between studies from different i...

Descripción completa

Detalles Bibliográficos
Autores principales: Klawer, Edzo M.E., van Houdt, Petra J., Pos, Floris J., Heijmink, Stijn W.T.P.J., van Osch, Matthias J.P., van der Heide, Uulke A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175355/
https://www.ncbi.nlm.nih.gov/pubmed/29974981
http://dx.doi.org/10.1002/nbm.3946
_version_ 1783361490335563776
author Klawer, Edzo M.E.
van Houdt, Petra J.
Pos, Floris J.
Heijmink, Stijn W.T.P.J.
van Osch, Matthias J.P.
van der Heide, Uulke A.
author_facet Klawer, Edzo M.E.
van Houdt, Petra J.
Pos, Floris J.
Heijmink, Stijn W.T.P.J.
van Osch, Matthias J.P.
van der Heide, Uulke A.
author_sort Klawer, Edzo M.E.
collection PubMed
description The volume transfer constant K (trans), which describes the leakage of contrast agent (CA) from vasculature into tissue, is the most commonly reported quantitative parameter for dynamic contrast‐enhanced (DCE‐) MRI. However, the variation in reported K (trans) values between studies from different institutes is large. One of the primary sources of uncertainty is quantification of the arterial input function (AIF). The aim of this study is to determine the influence of the CA injection duration on the AIF and tracer kinetic analysis (TKA) parameters (i.e. K (trans), k (ep) and v (e)). Thirty‐one patients with prostate cancer received two DCE‐MRI examinations with an injection duration of 5 s in the first examination and a prolonged injection duration in the second examination, varying between 7.5 s and 30 s. The DCE examination was carried out on a 3.0 T MRI scanner using a transversal T (1)‐weighted 3D spoiled gradient echo sequence (300 s duration, dynamic scan time of 2.5 s). Data of 29 of the 31 were further analysed. AIFs were determined from the phase signal in the left and right femoral arteries. K (trans), k (ep) and v (e) were estimated with the standard Tofts model for regions of healthy peripheral zone and tumour tissue. We observed a significantly smaller peak height and increased width in the AIF for injection durations of 15 s and longer. However, we did not find significant differences in K (trans), k (ep) or v (e) for the studied injection durations. The study demonstrates that the TKA parameters K (trans), k(ep) and v (e), measured in the prostate, do not show a significant change as a function of injection duration.
format Online
Article
Text
id pubmed-6175355
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61753552018-10-19 Impact of contrast agent injection duration on dynamic contrast‐enhanced MRI quantification in prostate cancer Klawer, Edzo M.E. van Houdt, Petra J. Pos, Floris J. Heijmink, Stijn W.T.P.J. van Osch, Matthias J.P. van der Heide, Uulke A. NMR Biomed Research Articles The volume transfer constant K (trans), which describes the leakage of contrast agent (CA) from vasculature into tissue, is the most commonly reported quantitative parameter for dynamic contrast‐enhanced (DCE‐) MRI. However, the variation in reported K (trans) values between studies from different institutes is large. One of the primary sources of uncertainty is quantification of the arterial input function (AIF). The aim of this study is to determine the influence of the CA injection duration on the AIF and tracer kinetic analysis (TKA) parameters (i.e. K (trans), k (ep) and v (e)). Thirty‐one patients with prostate cancer received two DCE‐MRI examinations with an injection duration of 5 s in the first examination and a prolonged injection duration in the second examination, varying between 7.5 s and 30 s. The DCE examination was carried out on a 3.0 T MRI scanner using a transversal T (1)‐weighted 3D spoiled gradient echo sequence (300 s duration, dynamic scan time of 2.5 s). Data of 29 of the 31 were further analysed. AIFs were determined from the phase signal in the left and right femoral arteries. K (trans), k (ep) and v (e) were estimated with the standard Tofts model for regions of healthy peripheral zone and tumour tissue. We observed a significantly smaller peak height and increased width in the AIF for injection durations of 15 s and longer. However, we did not find significant differences in K (trans), k (ep) or v (e) for the studied injection durations. The study demonstrates that the TKA parameters K (trans), k(ep) and v (e), measured in the prostate, do not show a significant change as a function of injection duration. John Wiley and Sons Inc. 2018-07-05 2018-09 /pmc/articles/PMC6175355/ /pubmed/29974981 http://dx.doi.org/10.1002/nbm.3946 Text en © 2018 The Authors. NMR in Biomedicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Klawer, Edzo M.E.
van Houdt, Petra J.
Pos, Floris J.
Heijmink, Stijn W.T.P.J.
van Osch, Matthias J.P.
van der Heide, Uulke A.
Impact of contrast agent injection duration on dynamic contrast‐enhanced MRI quantification in prostate cancer
title Impact of contrast agent injection duration on dynamic contrast‐enhanced MRI quantification in prostate cancer
title_full Impact of contrast agent injection duration on dynamic contrast‐enhanced MRI quantification in prostate cancer
title_fullStr Impact of contrast agent injection duration on dynamic contrast‐enhanced MRI quantification in prostate cancer
title_full_unstemmed Impact of contrast agent injection duration on dynamic contrast‐enhanced MRI quantification in prostate cancer
title_short Impact of contrast agent injection duration on dynamic contrast‐enhanced MRI quantification in prostate cancer
title_sort impact of contrast agent injection duration on dynamic contrast‐enhanced mri quantification in prostate cancer
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175355/
https://www.ncbi.nlm.nih.gov/pubmed/29974981
http://dx.doi.org/10.1002/nbm.3946
work_keys_str_mv AT klaweredzome impactofcontrastagentinjectiondurationondynamiccontrastenhancedmriquantificationinprostatecancer
AT vanhoudtpetraj impactofcontrastagentinjectiondurationondynamiccontrastenhancedmriquantificationinprostatecancer
AT posflorisj impactofcontrastagentinjectiondurationondynamiccontrastenhancedmriquantificationinprostatecancer
AT heijminkstijnwtpj impactofcontrastagentinjectiondurationondynamiccontrastenhancedmriquantificationinprostatecancer
AT vanoschmatthiasjp impactofcontrastagentinjectiondurationondynamiccontrastenhancedmriquantificationinprostatecancer
AT vanderheideuulkea impactofcontrastagentinjectiondurationondynamiccontrastenhancedmriquantificationinprostatecancer